Cargando…
肺腺癌吉非替尼获得性耐药相关microRNAs的筛选鉴定
BACKGROUND AND OBJECTIVE: Acquired gefitinib-resistance was closely related to inefficiency of EGFRTKI treatment in lung adenocarcinoma. However, it was not clear that how microRNAs influenced the acquired gefitinibresistance in lung adenocarcinoma. The aim of this study is to screen and identify th...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999882/ https://www.ncbi.nlm.nih.gov/pubmed/21645449 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.18 |
Ejemplares similares
-
吉非替尼可能通过EGFR启动子甲基化诱导肺腺癌细胞继发性耐药
Publicado: (2015) -
吉非替尼耐药的人肺腺癌HCC-827/GR细胞乙醛脱氢酶亚型表达分析
Publicado: (2018) -
TRIM24介导肺癌细胞吉非替尼耐药机制探讨
Publicado: (2016) -
干扰FOXC1逆转非小细胞肺癌吉非替尼耐药的作用
Publicado: (2021) -
下调HOTAIR通过提高PTEN表达逆转HCC827细胞吉非替尼耐药
Publicado: (2020)